Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 11 / Drugs : 14 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 66

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Cannabidiol
   Anne Comi, MD
      2019   Phase 2   NCT04447846   United States
      2014   Phase 1/Phase 2   NCT02332655   United States
Crema DE rapamicina AL 1% Y excipientes
   Instituto Científico y Tecnológico de Navarra
      2011   -   EUCTR2010-024078-20-ES   Spain
Drug: topical rapamycin
   Clinica Universidad de Navarra, Universidad de Navarra
      2011   Phase 2   NCT02080624   Spain
Everolimus
   Baylor College of Medicine
      2014   Phase 2   NCT01997255   United States
Haemoblock
   Center for Vascular Pathology, Moscow
      2020   Phase 4   NCT04999618   Russian Federation
Modified atkins diet
   Johns Hopkins University
      2006   Phase 1   NCT00639730   United States
Rapamicina Tópica AL 1% Y excipiente
   Instituto Científico y Tecnológico de Navarra
      2011   -   EUCTR2010-024078-20-ES   Spain
Sirolimus
   Anne Comi, MD
      2017   Phase 2/Phase 3   NCT03047980   United States
Timolol
   Wills Eye
      2012   Phase 1   NCT01533376   United States